scholarly article | Q13442814 |
P50 | author | Alan T. Remaley | Q91944002 |
P2093 | author name string | Zhigang Chen | |
Alexander Bocharov | |||
Amy P Patterson | |||
Thomas L Eggerman | |||
John Stonik | |||
Irina Baranova | |||
Tatyana Vishnyakova | |||
P2860 | cites work | Lipopolysaccharide Inhibits the Expression of the Scavenger Receptor Cla-1 in Human Monocytes and Macrophages | Q62661497 |
Risk factors for coronary artery disease in patients with systemic lupus erythematosus | Q67586359 | ||
Bacterial Endotoxins | Q68229988 | ||
Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta | Q70865443 | ||
Cytokine activation of endothelial cells: new molecules for an old paradigm | Q73447474 | ||
Wortmannin inhibits activation of nuclear transcription factors NF-kappaB and activated protein-1 induced by lipopolysaccharide and phorbol ester | Q73763994 | ||
Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion | Q73764728 | ||
LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha | Q73877000 | ||
Apolipoprotein-mediated cellular cholesterol efflux | Q74567612 | ||
Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface | Q74580044 | ||
The response-to-retention hypothesis of atherogenesis reinforced | Q77542561 | ||
Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency | Q77795559 | ||
Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation | Q78031825 | ||
The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway | Q22010685 | ||
Characterization of CLA-1, a Human Homologue of Rodent Scavenger Receptor BI, as a Receptor for High Density Lipoprotein and Apoptotic Thymocytes | Q24315731 | ||
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
Characterization of a 95 kDa high affinity human high density lipoprotein-binding protein | Q28210157 | ||
Identification of scavenger receptor SR-BI as a high density lipoprotein receptor | Q28273182 | ||
The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
Atherosclerosis. the road ahead | Q29618972 | ||
NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control | Q29620172 | ||
Regulation of the cholesterol efflux gene, ABCA1. | Q32048900 | ||
ABC transporters and cholesterol metabolism | Q32068701 | ||
Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor | Q33182099 | ||
Cell cholesterol efflux: integration of old and new observations provides new insights. | Q33605655 | ||
Tangier disease and ABCA1. | Q33927615 | ||
Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. | Q33999960 | ||
LPS induction of gene expression in human monocytes | Q34189313 | ||
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities | Q34668829 | ||
Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells | Q35488540 | ||
Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities | Q37075986 | ||
Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. | Q37358799 | ||
Chlamydia pneumoniae and atherosclerosis: links to the disease process | Q37877547 | ||
A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide | Q37879971 | ||
Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery | Q37882074 | ||
Chronic infections and coronary heart disease: is there a link? | Q37882245 | ||
: Risk factors for seropositivity and association with coronary heart disease | Q37887420 | ||
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
Adjunctive therapy for septic shock: a review of experimental approaches | Q40512090 | ||
Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. | Q40726858 | ||
Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-alpha through a post-transcriptional mechanism | Q40804847 | ||
Nuclear factor kappa B, a mediator of lipopolysaccharide effects | Q40825105 | ||
Enhancement of the cAMP-induced apolipoprotein-mediated cellular lipid release by calmodulin inhibitors W7 and W5 from RAW 264 mouse macrophage cell line cells | Q40844087 | ||
An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression | Q40856439 | ||
ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. | Q40864517 | ||
Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. | Q40864887 | ||
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling | Q41006478 | ||
Endotoxin signal transduction in macrophages. | Q41027506 | ||
Endotoxin: possible roles in initiation and development of atherosclerosis | Q41195257 | ||
Apolipoprotein-mediated removal of cellular cholesterol and phospholipids | Q41337903 | ||
NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. | Q41454872 | ||
NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. | Q41545817 | ||
Cell-mediated immunity in atherosclerosis. | Q41614969 | ||
Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells | Q42488978 | ||
Cellular localization and trafficking of the human ABCA1 transporter | Q43604836 | ||
Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin | Q44596079 | ||
Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation | Q45867537 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lipopolysaccharide | Q421804 |
P304 | page(s) | 2995-3003 | |
P577 | publication date | 2002-06-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells | |
P478 | volume | 70 |
Q45183033 | A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense. |
Q36192289 | ABCA1 and atherosclerosis. |
Q34053118 | ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance |
Q36542860 | ABCA1, from pathology to membrane function |
Q58710934 | AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation |
Q34112680 | ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport |
Q35791601 | Acute tubular injury causes dysregulation of cellular cholesterol transport proteins |
Q37726950 | Aortic cholesterol accumulation correlates with systemic inflammation but not hepatic and gonadal adipose tissue inflammation in low-density lipoprotein receptor null mice |
Q33436431 | Arabinoxylan rice bran (Biobran) suppresses the viremia level in patients with chronic HCV infection: A randomized trial. |
Q37535601 | Artesunate reduces serum lipopolysaccharide in cecal ligation/puncture mice via enhanced LPS internalization by macrophages through increased mRNA expression of scavenger receptors |
Q34897630 | Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study |
Q37811885 | Atherosclerosis in chronic kidney disease: the role of macrophages |
Q24298291 | Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1 |
Q42820258 | Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivo. |
Q33761855 | CD4+ T lymphocyte subsets express connexin 43 and establish gap junction channel communication with macrophages in vitro. |
Q26752101 | Caveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in Atherosclerosis |
Q36301730 | Chronically active: activation of microglial proteolysis in ageing and neurodegeneration. |
Q34261102 | Deficiency of glycine N-methyltransferase aggravates atherosclerosis in apolipoprotein E-null mice |
Q38848673 | Detection and treatment of atherosclerosis using nanoparticles |
Q38858262 | Emerging hepatic syndromes: pathophysiology, diagnosis and treatment. |
Q34109998 | Enhanced aortic macrophage lipid accumulation and inflammatory response in LDL receptor null mice fed an atherogenic diet |
Q38376197 | Exploring the link between scavenger receptor B1 expression and chronic obstructive pulmonary disease pathogenesis |
Q35928192 | Human immunodeficiency virus protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage-derived foam cells |
Q33687732 | Identification and activation of TLR4-mediated signalling pathways by alginate-derived guluronate oligosaccharide in RAW264.7 macrophages. |
Q46060118 | Identification of dehydroxytrichostatin A as a novel up-regulator of the ATP-binding cassette transporter A1 (ABCA1). |
Q37077796 | Inflammation impairs reverse cholesterol transport in vivo. |
Q38370895 | Inflammation-induced foam cell formation in chronic inflammatory disease. |
Q88920922 | Inhibition of Neuroinflammation by AIBP: Spinal Effects upon Facilitated Pain States |
Q42819606 | Involvement of cathepsins B and L in inflammation and cholesterol trafficking protein NPC2 secretion in macrophages. |
Q37733535 | Lipid content in hepatic and gonadal adipose tissue parallel aortic cholesterol accumulation in mice fed diets with different omega-6 PUFA to EPA plus DHA ratios |
Q34073849 | Lipopolysaccharide decreases single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) expression by suppressing specificity protein 1 (Sp1) via the Toll-like receptor 4 (TLR4)-p38 pathway in monocytes and neutrophils |
Q42500474 | Lipopolysaccharide represses the expression of ATP-binding cassette transporter G1 and scavenger receptor class B, type I in murine macrophages |
Q37597310 | Liver X Receptor: Crosstalk Node for the Signaling of Lipid Metabolism, Carbohydrate Metabolism, and Innate Immunity |
Q35203793 | Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment |
Q39741605 | MCP-1 impacts RCT by repressing ABCA1, ABCG1, and SR-BI through PI3K/Akt posttranslational regulation in HepG2 cells |
Q36949620 | Macrophage-activating lipopeptide-2 downregulates the expression of ATP-binding cassette transporter A1 by activating the TLR2/NF-кB/ZNF202 pathway in THP-1 macrophages |
Q36534100 | Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin |
Q34966302 | Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation |
Q33741235 | Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2) |
Q35660172 | PPARγ Agonists Attenuate Palmitate-Induced ER Stress through Up-Regulation of SCD-1 in Macrophages |
Q44586596 | Periodontitis decreases the antiatherogenic potency of high density lipoprotein |
Q51090021 | Peripheral Blood Mononuclear Cell ABCA1 Transcripts and Protein Expression in Acute Myocardial Infarction. |
Q41848049 | Potential down-regulation of salivary gland AQP5 by LPS via cross-coupling of NF-kappaB and p-c-Jun/c-Fos. |
Q38261037 | Practical strategies for modulating foam cell formation and behavior |
Q36103915 | Proteomic Analysis of ABCA1-Null Macrophages Reveals a Role for Stomatin-Like Protein-2 in Raft Composition and Toll-Like Receptor Signaling. |
Q40202893 | ROS and NF-kappaB but not LXR mediate IL-1beta signaling for the downregulation of ATP-binding cassette transporter A1. |
Q33679873 | Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse |
Q37318534 | Regulation of macrophage function in inflammation and atherosclerosis |
Q37357219 | Renal dysfunction potentiates foam cell formation by repressing ABCA1. |
Q50313295 | Scavenger receptor B1 post-translational modifications in Rett syndrome. |
Q34246570 | Scavenger receptor class B type I: a multifunctional receptor |
Q47598350 | Scavenger receptor expressed by endothelial cells I (SREC-I) mediates the uptake of acetylated low density lipoproteins by macrophages stimulated with lipopolysaccharide |
Q40240250 | Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells |
Q28296257 | Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases |
Q28507352 | Suppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype |
Q40544969 | Targeting of scavenger receptor class B type I by synthetic amphipathic alpha-helical-containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells |
Q98159170 | The Inhibition of miR-873 Provides Therapeutic Benefit in a Lipopolysaccharide-Induced Neuroinflammatory Model of Parkinson's Disease |
Q39710687 | The acute phase response inhibits reverse cholesterol transport |
Q46953942 | The effect of PPARalpha and PPARgamma ligands on inflammation and ABCA1 expression in cultured gallbladder epithelial cells |
Q34340237 | The hepatoadrenal syndrome: a common yet unrecognized clinical condition |
Q33521232 | The role of scavenger receptor B1 in infection with Mycobacterium tuberculosis in a murine model |
Q34273619 | The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders |
Q27008289 | Update on adrenal insufficiency in patients with liver cirrhosis |
Q34776276 | Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport |
Search more.